Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone is the most effective treatment for hair regrowth in alopecia areata patients.

Dermal papilla cells help wounds heal better and can potentially grow new hair.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

The new method for isolating stem cells from fat is simple and effective, producing cells that grow faster and are better for hair regeneration.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Induced pluripotent stem cells could improve chronic wound healing but face safety and effectiveness challenges.

Umbilical cord and cord blood stem cells are promising for treating chronic diseases due to their versatility and ethical acceptability.

Six key genes can predict bladder cancer outcomes and may serve as prognostic biomarkers.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Changing how mesenchymal stromal cells are grown can improve their healing abilities.

Mesenchymal stem cells are key to future tissue regeneration in oral surgery.